Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 86.9% in January

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,207 shares, a decline of 86.9% from the December 31st total of 9,193 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average trading volume of 40,068 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 40,068 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Cardiac Biotech Solutions Price Performance

OTCMKTS CBSC traded down $0.00 on Tuesday, reaching $0.03. The company’s stock had a trading volume of 4,500 shares, compared to its average volume of 13,723. Cardiac Biotech Solutions has a twelve month low of $0.02 and a twelve month high of $0.15. The firm’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.04.

Cardiac Biotech Solutions Company Profile

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.